A new stem cell-based treatment helped most trial participants with severe type 1 diabetes stop insulin use, offering hope ...

More than 8 million people globally suffer from type 1 diabetes, a condition where the immune system destroys ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 diabetes in whom the benefits outweigh the risks of immunosuppression.

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

Since the 1920s, the standard of care for type 1 diabetes was insulin replacement therapy—requiring millions of Americans to administer insulin via a pump or injection multiple times a day. There is a ...

Since the 1920s, the standard of care for type 1 diabetes was insulin replacement therapy—requiring millions of Americans to administer insulin via a pump or injection multiple times a day.

A study may have found a cure for type 1 diabetes. Here, experts explain how the treatment, zimislecel, works and what it ...

Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

Medicare covers many insulin pumps. Your coverage will depend on the type of pump you use. We explain Medicare coverage, costs, eligibility, and more.

First Canadian to receive procedure says she would do it ‘a million times over’ compared with previous work to keep blood ...